Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease
暂无分享，去创建一个
R. Xu | Siddharth Singh | B. Sands | C. Siegel | W. Sandborn | E. Loftus | P. Dulai | B. Boland | J. Colombel | Shannon Chang | A. Swaminath | G. Kochhar | S. Kane | D. Hudesman | D. Lukin | B. Shen | R. Hirten | M. Fischer | R. Ungaro | K. Lasch | E. Shmidt | M. Bohm | Yiran Zhang | Sashidhar Varma | Vipul Jairaith